SCHEMBL31435518

SCHEMBL31435518

O=C(OCc1ccccc1)N1CCC(=O)N2CCCC2CC1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.58
NPC1 O15118 2/20 0.58
RAB9A P51151 2/20 0.58
CYP2C19 P33261 1/20 0.56
HDAC1 Q13547 1/20 0.50
HDAC6 Q9UBN7 1/20 0.50
MEN1 O00255 1/20 0.50
KMT2A Q03164 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
TMEM97 Q5BJF2 5/20 0.48
SIGMAR1 Q99720 5/20 0.48
HTR1A P08908 2/20 0.48
HRH2 P25021 2/20 0.48
HRH1 P35367 2/20 0.48
HRH3 Q9Y5N1 2/20 0.48
CHRM4 P08173 1/20 0.48
CHRM5 P08912 1/20 0.48
ADRA2A P08913 1/20 0.48
ADRA2B P18089 1/20 0.48
ADRA1D P25100 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6969799 0.93 SMN1; SMN2 (0.61) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL4872217 0.92 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL2855664 0.91 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL4512387 0.85 SMN1; SMN2 (0.51) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL18032527 0.85 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL14334908 0.85 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL12815027 0.84 SMN1; SMN2 (0.50) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL17825392 0.84 SMN1; SMN2 (0.58) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL4869972 0.82 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP2C19HDAC1
SCHEMBL23187621 0.82 SMN1; SMN2 (0.52) SMN1; SMN2NPC1RAB9ACYP2C19MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119301127-A 6-Oxo-decahydro pyrrolo [1,2-a ] [1,5] diazocine and 6-oxo-decahydro-4H-pyrrolo [2,1-d ] [1,5] thiaazacine derivatives as modulators of STAT3 and STAT6 for the treatment of cancer and inflammatory conditions 瑞克鲁迪克斯制药股份有限公司 2025-01-10 CN disclosed